News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,062 Results
Type
Article (53255)
Company Profile (253)
Press Release (631530)
Multimedia
Podcasts (160)
Webinars (27)
Section
Business (186654)
Career Advice (2686)
Deals (33513)
Drug Delivery (154)
Drug Development (81702)
Employer Resources (189)
FDA (15631)
Job Trends (14700)
News (325714)
Policy (32273)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2825)
Academic (2)
Accelerated approval (42)
Adcomms (36)
Allergies (163)
Alliances (47859)
ALS (200)
Alzheimer's disease (1823)
Antibody-drug conjugate (ADC) (392)
Approvals (15892)
Artificial intelligence (646)
Autoimmune disease (228)
Automation (48)
Bankruptcy (345)
Best Places to Work (11196)
BIOSECURE Act (21)
Biosimilars (213)
Biotechnology (134)
Bladder cancer (174)
Brain cancer (65)
Breast cancer (684)
Cancer (5355)
Cardiovascular disease (476)
Career advice (2284)
Career pathing (45)
CAR-T (310)
CDC (62)
Cell therapy (820)
Cervical cancer (37)
Clinical research (70184)
Collaboration (1928)
Company closure (6)
Compensation (940)
Complete response letters (85)
COVID-19 (2803)
CRISPR (104)
C-suite (1041)
Cystic fibrosis (142)
Data (7025)
Decentralized trials (3)
Denatured (45)
Depression (167)
Dermatology (58)
Diabetes (560)
Diagnostics (6646)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (309)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (272)
Earnings (73511)
Editorial (69)
Employer branding (25)
Employer resources (164)
Events (104254)
Executive appointments (1093)
FDA (18962)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1576)
Gene editing (214)
Generative AI (61)
Gene therapy (703)
GLP-1 (1153)
Government (4853)
Grass and pollen (7)
Guidances (397)
Healthcare (17667)
HIV (77)
Huntington's disease (55)
IgA nephropathy (94)
Immunology and inflammation (310)
Immuno-oncology (85)
Indications (152)
Infectious disease (3125)
Inflammatory bowel disease (209)
Inflation Reduction Act (16)
Influenza (126)
Intellectual property (268)
Interviews (545)
IPO (14933)
IRA (59)
Job creations (3813)
Job search strategy (1863)
JPM (70)
Kidney cancer (20)
Labor market (96)
Layoffs (608)
Leadership (44)
Legal (7526)
Liver cancer (99)
Longevity (23)
Lung cancer (740)
Lymphoma (409)
Machine learning (46)
Management (60)
Manufacturing (938)
MASH (194)
Medical device (11862)
Medtech (11932)
Mergers & acquisitions (19697)
Metabolic disorders (1527)
mRNA (184)
Multiple sclerosis (174)
NASH (24)
Neurodegenerative disease (411)
Neuropsychiatric disorders (112)
Neuroscience (3277)
Neurotech (1)
NextGen: Class of 2026 (6326)
Non-profit (4408)
Now hiring (74)
Obesity (750)
Opinion (336)
Ovarian cancer (186)
Pain (241)
Pancreatic cancer (252)
Parkinson's disease (350)
Partnered (34)
Patents (551)
Patient recruitment (595)
Peanut (58)
People (60281)
Pharmaceutical (88)
Pharmacy benefit managers (36)
Phase 1 (21703)
Phase 2 (30758)
Phase 3 (23295)
Pipeline (7060)
Policy (345)
Postmarket research (2679)
Preclinical (9212)
Press Release (71)
Prostate cancer (276)
Psychedelics (60)
Radiopharmaceuticals (296)
Rare diseases (1044)
Real estate (5819)
Recruiting (77)
Regulatory (24881)
Reports (65)
Research institute (2530)
Resumes & cover letters (399)
Rett syndrome (32)
RNA editing (18)
RSV (89)
Schizophrenia (176)
Series A (267)
Series B (194)
Service/supplier (12)
Sickle cell disease (114)
Special edition (28)
Spinal muscular atrophy (172)
Sponsored (44)
Startups (3598)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (99)
The Weekly (112)
Vaccines (1096)
Venture capital (108)
Weight loss (508)
Women's health (96)
Worklife (23)
Date
Last 7 days (630)
Last 30 days (2497)
Last 365 days (29245)
2026 (7801)
2025 (29559)
2024 (34037)
2023 (38277)
2022 (49059)
2021 (53249)
2020 (51698)
2019 (44973)
2018 (34113)
2017 (31799)
2016 (31096)
2015 (35963)
2014 (28848)
2013 (24361)
2012 (26065)
2011 (26847)
2010 (24912)
Location
Africa (915)
Alabama (89)
Alaska (5)
Arizona (268)
Arkansas (14)
Asia (42826)
Australia (7839)
California (11211)
Canada (3448)
China (1245)
Colorado (501)
Connecticut (449)
Delaware (351)
Europe (94322)
Florida (1770)
Georgia (364)
Hawaii (4)
Idaho (55)
Illinois (942)
India (85)
Indiana (525)
Iowa (20)
Japan (497)
Kansas (120)
Kentucky (45)
Louisiana (38)
Maine (63)
Maryland (1414)
Massachusetts (8057)
Michigan (339)
Minnesota (623)
Mississippi (7)
Missouri (135)
Montana (28)
Nebraska (27)
Nevada (133)
New Hampshire (83)
New Jersey (3209)
New Mexico (29)
New York (3106)
North Carolina (1514)
North Dakota (9)
Northern California (5557)
Ohio (343)
Oklahoma (18)
Oregon (44)
Pennsylvania (2302)
Puerto Rico (27)
Rhode Island (49)
South America (1233)
South Carolina (73)
South Dakota (1)
Southern California (4393)
Tennessee (190)
Texas (1837)
United States (40655)
Utah (351)
Vermont (1)
Virginia (292)
Washington D.C. (81)
Washington State (947)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
685,062 Results for "aureus sciences formerly known as aureus pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales
While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established itself as the clear leader in the obesity market, in the process capturing investors’ attention and enthusiasm.
March 18, 2026
·
8 min read
·
Tristan Manalac
Job Trends
Beyond the Cornfields, Indiana’s Life Sciences Industry Grows Tall
With thousands of companies and a $102 billion impact on the state’s economy, Indiana’s life sciences industry is making its mark. The president and CEO of the Indiana Life Sciences Association discusses the sector’s upside, challenges and where it’s headed in the future.
March 26, 2026
·
5 min read
·
Angela Gabriel
Press Releases
Vicore Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
February 18, 2026
·
1 min read
Press Releases
Armata Pharmaceuticals Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia
May 19, 2025
·
7 min read
Press Releases
Notice of Annual General Meeting in Ascelia Pharma AB
March 30, 2026
·
40 min read
Press Releases
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
April 1, 2026
·
4 min read
Press Releases
COUR Pharma Publishes Peer-Reviewed Data in Science Advances
January 29, 2026
·
3 min read
Press Releases
As mental health patients turn to AI chatbots, how can pharma lead the way?
A new report by Bryter released today reveals where pharma can lead as patients turn to (and question) AI tools for mental health.
February 5, 2026
·
1 min read
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
Long a quieter, locally focused industry, Japanese pharma giants are increasingly looking to the rest of the world for deals.
December 10, 2025
·
7 min read
·
Dan Samorodnitsky
Press Releases
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
February 11, 2026
·
6 min read
Previous
2 of 68,507
Next
